The Vanguard Group Discloses Position in Life Science REIT plc

On 24 February 2026, The Vanguard Group, Inc. filed a Form 8.3 under the UK Takeover Code, disclosing its interest in Life Science REIT plc. As per the form, Vanguard holds 3,282,154 shares, representing 0.94% of the company's ordinary securities. The disclosure relates to the position held on 23 February 2026. Additionally, Vanguard disclosed dealings in British Land Company plc.

No cash-settled or stock-settled derivatives were listed, nor were there any agreements or understandings related to securities options. On the recorded date, Vanguard purchased 12,645 ordinary shares of Life Science REIT plc at 0.43 GBP per share. The document notes no indemnity agreements or other incentives, with all disclosures following Rule 8.3 of the Takeover Code.